Jefferies Financial Group Boosts Johnson Matthey (LON:JMAT) Price Target to GBX 2,420

Johnson Matthey (LON:JMAT) had its target price upped by equities research analysts at Jefferies Financial Group from GBX 2,200 to GBX 2,420 in a research report issued to clients and investors on Tuesday,London Stock Exchange reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s target price points to a potential upside of 15.02% from the stock’s current price.

Several other equities research analysts have also issued reports on JMAT. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research note on Thursday, October 9th. Berenberg Bank boosted their target price on shares of Johnson Matthey from GBX 1,950 to GBX 2,100 and gave the stock a “hold” rating in a research report on Thursday, October 9th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,273.33.

Johnson Matthey Trading Up 0.3%

LON JMAT opened at GBX 2,104 on Tuesday. Johnson Matthey has a twelve month low of GBX 1,131 and a twelve month high of GBX 2,114. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The stock has a market cap of £3.53 billion, a price-to-earnings ratio of 996.21, a PEG ratio of 49,242.50 and a beta of 0.95. The firm’s 50 day moving average price is GBX 1,919.90 and its two-hundred day moving average price is GBX 1,683.16.

Insider Activity

In other Johnson Matthey news, insider Andrew Cosslett bought 10,495 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The stock was acquired at an average price of GBX 1,896 per share, with a total value of £198,985.20. Insiders have acquired a total of 10,521 shares of company stock worth $19,948,290 over the last ninety days. 0.50% of the stock is owned by corporate insiders.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.